High-Dose DHA Clinical Trial Published
Phase IIa trial at USC demonstrates CNS target engagement of high-dose DHA supplementation in older adults at risk for dementia.
Read on PubMed →Led by Dr. Bilal E. Kerman at the University of Southern California, our research combines advanced quantitative imaging, machine learning, and human iPSC-based glial and neuronal models to uncover how lipid metabolism, APOE4, and cPLA2 signaling drive neurovascular inflammation and dementia.
Bridging lipid biology, quantitative microscopy, and stem-cell models of glia.
Dissecting how cytosolic phospholipase A2 (PLA2G4A), APOE4 lipid metabolism, ABCA1 trafficking, and ApoE glycosylation drive cerebral amyloid angiopathy (CAA), blood-brain barrier breakdown, and Alzheimer’s pathology.
Combining high-resolution confocal and label-free holotomographic microscopy with custom ImageJ/Fiji macros, Weka segmentation, and machine-learning algorithms (such as DeepMQ) to quantify cellular, vascular, and glial phenotypes.
Developing human iPSC-derived microglia, astrocytes, oligodendrocytes, neurons, and endothelial cells—alongside glia-neuron and immune-glia co-cultures and myelination assays—to model Alzheimer’s disease and demyelination.
Phase IIa trial at USC demonstrates CNS target engagement of high-dose DHA supplementation in older adults at risk for dementia.
Read on PubMed →Dr. Bilal Kerman presented recent findings on cPLA2-driven vascular inflammation in Alzheimer’s disease at the USC ADRC REC Seminar.
Seminar Details →Our perspective on targeting cPLA2/PLA2G4A to mitigate BBB dysfunction, CAA, and ARIA risk in APOE4 carriers is published.
Read Full Text (PMC) →We are happy to share our protocols, ImageJ/Fiji macros, machine-learning quantification tools (including DeepMQ), and stem-cell differentiation workflows with the neuroscience community.
We welcome collaboration opportunities across neurovascular biology, iPSC glial modeling, lipidomics, and quantitative imaging, as well as inquiries from motivated students and postdoctoral fellows at USC.
At the Keck School of Medicine of USC and the USC Center for Personalized Brain Health, our work investigates why the aging brain becomes vulnerable to vascular inflammation, lipid dysregulation, and neurodegeneration—and how quantitative imaging and human iPSC glial models can accelerate therapeutic discovery.
Vascular inflammation and cerebral amyloid angiopathy (CAA) are major drivers of Alzheimer’s disease progression, especially in APOE4 carriers who face elevated risk of amyloid-related imaging abnormalities (ARIA). We investigate how calcium-dependent cytosolic phospholipase A2 (cPLA2) cleaves membrane phospholipids to release arachidonic acid, amplifying oxidative stress, blood-brain barrier breakdown, and excitatory synaptic loss—alongside ABCA1 cholesterol pathways, ApoE glycosylation, and brain omega-3/DHA utilization.
To reconcile in vitro cellular phenotypes with human and mouse brain tissue, we pair high-resolution confocal (Zeiss Airyscan) and label-free holotomographic microscopy with automated computational pipelines—spanning custom ImageJ/Fiji macros, Trainable Weka Segmentation, machine-learning algorithms for fluorescence quantification (patented DeepMQ), and ML-assisted astrocyte calcium-response analysis.
Glial cells are central regulators of neuroinflammation and brain homeostasis. We develop human iPSC-derived microglia, astrocytes, oligodendrocytes, neurons, and endothelial cells—as well as glia-neuron and macrophage-oligodendrocyte co-cultures—to study APOE4-driven microglial senescence, ABCA1/cPLA2 signaling, and stem-cell-based myelination and remyelination biology.
We translate mechanistic findings into therapeutic and biomarker strategies—collaborating on potent, selective brain-penetrant cPLA2 inhibitors, PET lipid-uptake probes, ApoE glycosylation biomarkers, and clinical trials evaluating DHA target engagement in older adults at risk for dementia.
Our collaborative research at USC is supported by the National Institute on Aging (NIH/NIA) and the Alzheimer’s Drug Discovery Foundation, alongside prior and ongoing international support from TÜBİTAK, the Turkish Academy of Sciences, Marie Skłodowska-Curie Actions, and NEUBIAS.
Principal Investigator, USC collaborators, and international alumni network.
Assistant Professor of Research, Department of Medicine & Department of Neurology · Keck School of Medicine of USC
Dr. Kerman investigates cellular and molecular mechanisms of Alzheimer’s disease, cerebral amyloid angiopathy (CAA), APOE4 lipid metabolism, and neurovascular inflammation at the USC Center for Personalized Brain Health. He earned his B.S. in Molecular Biology and Genetics from Bilkent University, his Ph.D. in Biochemistry, Cellular and Molecular Biology from Johns Hopkins University, and completed postdoctoral training in neural stem cells and myelination with Dr. Fred H. Gage at the Salk Institute before leading a lab at Istanbul Medipol University (REMER).
USC Center for Personalized Brain Health & Keck School of Medicine
We are interested in mentoring motivated postdoctoral researchers, graduate students, and USC undergraduates passionate about iPSC glial models, neurovascular inflammation, and machine-learning-assisted quantitative imaging.
Behçet Uğur Töreyin, Ph.D. (ITU), Abdulkerim Çapar, Ph.D. (ITU), Umut E. Ayten, Ph.D. (YTU), Sibel Çimen, Dursun A. Ekinci
Pavle R. Andjus, Ph.D. (University of Belgrade), Neşe Ayşit, Ph.D. (Istanbul Medipol University)
Fred H. Gage, Ph.D. (Salk Institute), Zeynep Aladağ, Burcu Kurt Vatandaşlar, Nurhan Özlü, Ph.D. (Koç University)
Selected peer-reviewed articles and patents.
We share protocols, machine-learning image-analysis workflows, and educational materials to support reproducible neuroscience.
Custom ImageJ Macro (.ijm) scripts, Trainable Weka Segmentation pipelines for automated cell and tissue feature classification, machine-learning algorithms for fluorescence quantification (DeepMQ), and automated astrocyte calcium-imaging analysis.
ML Quantification Paper (2020) ↗Protocols for differentiating human iPSCs into microglia, astrocytes, oligodendrocytes, and endothelial cells, alongside macrophage–oligodendrocyte co-cultures and stem-cell-based in vitro myelination assays.
Myelination Assay (Development 2015) ↗Course materials covering light and confocal microscopy, histology, neural tissue development, and culturally responsive, active-learning approaches to mentoring undergraduate and graduate researchers.
Public outreach on brain aging, Alzheimer’s prevention, and neurodegenerative disease awareness, featuring our upcoming Turkish-language healthy aging and geroscience podcast yaşlanMA.
Recent publications, seminars, and milestones from the Kerman Lab at USC.
A two-year randomised, double-blind, placebo-controlled trial at USC (NCT03613844) showed that high-dose DHA supplementation increased CSF DHA levels in older adults at risk for dementia, highlighting the need to understand brain lipid utilization in aging.
PubMed Abstract ↗Dr. Bilal Kerman delivered an invited seminar for the USC Alzheimer’s Disease Research Center (ADRC) Research Education Component series on cPLA2 signaling at the neurovascular unit.
USC ADRC Event Page ↗Our team published both a Perspective proposing PLA2G4A/cPLA2 as a drug target for vascular inflammation and CAA, and an experimental study demonstrating cPLA2 activation in Alzheimer’s disease synaptic pathology.
USC-led research published in Molecular Neurodegeneration highlighted lysosomal ABCA1, oxysterols, and cPLA2 as upstream targets in APOE4 and Alzheimer’s disease.
Interested in collaborating, requesting protocols, or joining the lab at USC? Reach out directly via email or use the inquiry composer.
A Turkish-language science communication podcast on healthy aging, geroscience, and brain health—co-hosted by Dr. Bilal Kerman. First episodes are in production and launching soon.
Public outreach on brain aging, Alzheimer’s prevention, and neurodegenerative disease awareness, featuring our upcoming Turkish-language healthy aging and geroscience podcast yaşlanMA.